The Great News – Lifestyle
Home
Sample Page
Author:
Cantargia
Cantargia Publishes Interim Report for The First Quarter of 2026
May 19, 2026
Invitation to the Presentation of Cantargia’s Interim Report for Q1 2026
May 6, 2026
Cantargia Announces Early Results from Trial of Nadunolimab in MDS and AML
April 29, 2026
Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC
April 28, 2026
Notice of Annual General Meeting in Cantargia AB (publ)
April 28, 2026
Cantargia Publishes Annual Report 2025
April 28, 2026
New Preclinical Data on Anti-Tumor Effects of Nadunolimab in Metastatic Colorectal Cancer Presented at the Keystone Cancer Immunotherapy Conference
March 18, 2026